Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Wood

Showing results (31-40 of 341) with videos related to

Pageof 35
Sort By:
European Urology|August 4, 2009
Words of wisdom. Re: Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomized, placebo- controlled phase III trialStephen H Culp, Christopher G Wood
European Urology|February 27, 2013
Words of wisdom: re: prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trialsJose A Karam, Christopher G Wood
Future Oncology (London, England)|August 12, 2009
Role of cytoreductive nephrectomy in renal cell carcinomaEdmund Chiong, Christopher G Wood, Vitaly Margulis
The Journal of Urology|July 24, 2012
Novel agents and approaches for advanced renal cell carcinomaRobert Figlin, Cora Sternberg, Christopher G Wood
Current Opinion in Urology|August 2, 2008
Cytoreductive nephrectomy in metastatic renal cell carcinomaVitaly Margulis, Surena F Matin, Christopher G Wood
European Urology|December 3, 2014
Reporting geographic and temporal trends in renal cell carcinoma: why is this important?Mehrad Adibi, Jose A Karam, Christopher G Wood
Urology|February 9, 2020
EDITORIAL COMMENTDaniel D Shapiro, Jose A Karam, Christopher G Wood
Urologic Oncology|November 19, 2013
Biomarkers of renal cell carcinomaTin C Ngo, Christopher G Wood, Jose A Karam
World Journal of Urology|April 19, 2014
Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapyDae Y Kim, Jose A Karam, Christopher G Wood
The Urologic Clinics of North America|November 3, 2011
The role of lymph node dissection in renal cell carcinomaScott E Delacroix, Brian F Chapin, Christopher G Wood
Pageof 35

Showing results (31-40 of 341) with videos related to

Sort By:
Pageof 35
European Urology|August 4, 2009
Words of wisdom. Re: Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomized, placebo- controlled phase III trialStephen H Culp, Christopher G Wood
European Urology|February 27, 2013
Words of wisdom: re: prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trialsJose A Karam, Christopher G Wood
Future Oncology (London, England)|August 12, 2009
Role of cytoreductive nephrectomy in renal cell carcinomaEdmund Chiong, Christopher G Wood, Vitaly Margulis
The Journal of Urology|July 24, 2012
Novel agents and approaches for advanced renal cell carcinomaRobert Figlin, Cora Sternberg, Christopher G Wood
Current Opinion in Urology|August 2, 2008
Cytoreductive nephrectomy in metastatic renal cell carcinomaVitaly Margulis, Surena F Matin, Christopher G Wood
European Urology|December 3, 2014
Reporting geographic and temporal trends in renal cell carcinoma: why is this important?Mehrad Adibi, Jose A Karam, Christopher G Wood
Urology|February 9, 2020
EDITORIAL COMMENTDaniel D Shapiro, Jose A Karam, Christopher G Wood
Urologic Oncology|November 19, 2013
Biomarkers of renal cell carcinomaTin C Ngo, Christopher G Wood, Jose A Karam
World Journal of Urology|April 19, 2014
Role of metastasectomy for metastatic renal cell carcinoma in the era of targeted therapyDae Y Kim, Jose A Karam, Christopher G Wood
The Urologic Clinics of North America|November 3, 2011
The role of lymph node dissection in renal cell carcinomaScott E Delacroix, Brian F Chapin, Christopher G Wood
Pageof 35